Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Büscheck

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Clinical Case Reports|June 17, 2024
An unusual clinical presentation of a plunging ranula-The plunging ranula with extension to the valleculaLisa Schmitz, Franziska Büscheck, Christian Stefan Betz, et al.
Journal of Interventional Cardiology|August 3, 2006
Patent foramen ovale using the Premere device: the results of the CLOSEUP trialFranziska Büscheck, Horst Sievert, Franz Kleber, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2007
Percutaneous devices for stroke preventionYves L Bayard, Stefan H Ostermayer, Ralph Hein, et al.
Journal of Interventional Cardiology|December 13, 2005
Atrial and ventricular septal defects can safely be closed by percutaneous interventionRalph Hein, Franziska Büscheck, Evelyn Fischer, et al.
The American Journal of Cardiology|April 26, 2008
Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder)Margaret Taaffe, Evelyn Fischer, Andreas Baranowski, et al.
Clinical Oral Investigations|July 23, 2016
CD151 expression is frequent but unrelated to clinical outcome in head and neck cancerJulie C Nienstedt, Alexander Gröbe, Patrick Lebok, et al.
Urologia Internationalis|September 21, 2018
Evaluating Guideline Adherence for T1 Bladder Cancer Treatment and Surveillance: A Retrospective German Multicenter ObservationMalte W Vetterlein, Philipp Gild, Phillip Marks, et al.
Urologic Oncology|May 23, 2022
Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16Maximilian Lennartz, Henrietta Csomós, Christian Bernreuther, et al.
Translational Andrology and Urology|January 23, 2018
Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladderMalte W Vetterlein, Julia Roschinski, Philipp Gild, et al.
Annals of Translational Medicine|March 12, 2021
Y-chromosome loss is frequent in male renal tumorsFranziska Büscheck, Christoph Fraune, Seyedehmina Garmestani, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Clinical Case Reports|June 17, 2024
An unusual clinical presentation of a plunging ranula-The plunging ranula with extension to the valleculaLisa Schmitz, Franziska Büscheck, Christian Stefan Betz, et al.
Journal of Interventional Cardiology|August 3, 2006
Patent foramen ovale using the Premere device: the results of the CLOSEUP trialFranziska Büscheck, Horst Sievert, Franz Kleber, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2007
Percutaneous devices for stroke preventionYves L Bayard, Stefan H Ostermayer, Ralph Hein, et al.
Journal of Interventional Cardiology|December 13, 2005
Atrial and ventricular septal defects can safely be closed by percutaneous interventionRalph Hein, Franziska Büscheck, Evelyn Fischer, et al.
The American Journal of Cardiology|April 26, 2008
Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder)Margaret Taaffe, Evelyn Fischer, Andreas Baranowski, et al.
Clinical Oral Investigations|July 23, 2016
CD151 expression is frequent but unrelated to clinical outcome in head and neck cancerJulie C Nienstedt, Alexander Gröbe, Patrick Lebok, et al.
Urologia Internationalis|September 21, 2018
Evaluating Guideline Adherence for T1 Bladder Cancer Treatment and Surveillance: A Retrospective German Multicenter ObservationMalte W Vetterlein, Philipp Gild, Phillip Marks, et al.
Urologic Oncology|May 23, 2022
Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16Maximilian Lennartz, Henrietta Csomós, Christian Bernreuther, et al.
Translational Andrology and Urology|January 23, 2018
Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladderMalte W Vetterlein, Julia Roschinski, Philipp Gild, et al.
Annals of Translational Medicine|March 12, 2021
Y-chromosome loss is frequent in male renal tumorsFranziska Büscheck, Christoph Fraune, Seyedehmina Garmestani, et al.
Pageof 12